You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

September 18, 2015

Thailand’s New Alcohol Labeling and Message Requirements

Bangkok Post, Corporate Counsellor Column

On January 22, the government issued a new notification, published in the Royal Gazette, setting out controversial labeling and message restrictions for alcoholic beverages that could result in major losses for the alcohol industry. It is being challenged before the Administrative Court, but pending the outcome of that case it has come into effect on April 22.

The Notification of Alcoholic Beverages Control Re: Rules, Procedures, and Conditions for Labels of Alcoholic Beverages, as it is formally known, is based on the Alcoholic Beverage Control Act of 2008 and its subsequent 2010 Ministerial Regulation, under which alcoholic beverages cannot be advertised in any way that boasts of efficacies, benefits, or qualities, or induces one to drink.

In January 2014, the Public Health Ministry notified the World Trade Organization (WTO) Committee on Sanitary and Phytosanitary Measures of proposed labeling requirements for alcoholic beverages. The draft notification prohibited the use of various types of messages on alcoholic beverage labels and packages including any message “which misleads consumers on the content of products” and any message “using the picture of a cartoon.”

The ministry issued a revised draft notification in August 2014 that combined the labeling restrictions with measures mandating graphic health warnings on alcoholic beverage packaging. Thailand would be the first country in the world to do so. It had earlier introduced the concept of graphic health warnings on alcoholic beverage packaging in 2010, but after details of the proposal reached the WTO Technical Barriers to Trade Committee, no more was heard of the proposal.

Last December, the ministry signed the final version of the notification without the graphic health warning provisions but with revised versions of the labeling and message restrictions. They include prohibitions on “a message which materially misleads consumers on the content of products” and “a message using cartoon images except images which are trademarks of alcoholic beverages which have been legitimately registered prior to enforcement of this Notification.”

Alcoholic beverages have long been branded and marketed with labels, containers, and packaging containing important messages depicted graphically that have been registered as trademarks and/or service marks. The ministry is likely to argue that many such future trademarks unregistered before April 22 violate the requirements in the notification, and therefore operators would be prohibited from displaying such trademarks on their products in Thailand. This would prevent rights holders from using their trademarks in accordance with their registration and put those marks at risk of cancellation based on non-use.

With the notification now in effect, the ministry appears to be moving once more toward reintroducing requirements for graphic health warnings on alcoholic beverage packaging. In 2010 and last year, the ministry proposed the introduction of graphic health warnings akin to those already in place for tobacco products.

In a novel move, the ministry staged a public competition to design new graphic health warnings for alcoholic beverage packaging. The competition requires that entries:

  • may use any graphic design technique including painting and photography;
  • must warn the public of the harms and consequences of alcoholic beverage consumption;
  • must aim at deterring children, teenagers, and the public to refrain from consuming alcoholic beverages;
  • must also contain “warning phrases;” and
  • must comply with all relevant intellectual property (IP) laws and be new and not previously submitted in any other contest or published in any magazine or website.

Contest participants must agree to transfer all IP rights related to the submission to the Thai Alcohol Control Committee. Prizes of THB 2,000 to THB 50,000 were offered for the winning designs, and the deadline for submissions was August 31. The competition is a clear attempt to drum up support for the imposition of graphic health warnings and raise significant awareness of the issue.

However, the delegation of this part of the regulatory process to the general public is bound to raise questions about whether any notification or regulation is based on internationally recognized principles of evidence-based policymaking. As such, can it be demonstrated to be an effective and proportionate measure to tackle genuine public health and social harms associated with alcoholic beverages?

The blanket imposition of large graphic health warnings on all alcoholic beverage products is also likely to meet opposition from manufacturers and importers on the basis that it unreasonably restricts their right to use their lawfully registered trademarks to market their legal products to adult consumers.

Ministerial notifications are, however, subject to legal challenge in the Administrative Court, which has the power to overturn or amend unlawful acts by administrative agencies or state officials. The court may issue an injunctive order suspending execution of the measure pending the outcome of the challenge.

RELATED INSIGHTS​ 

February 26, 2026
Laos’ Food and Drug Department (FDD) has been using a new online registration system for drugs since the beginning of the year. The system, which was implemented following the November 2025 issuance of Notice No. 5960/FDD, became the official pathway for submissions on January 1, 2026. Since that date, paper-based registrations have no longer been accepted. This marks a significant advancement in the digitalization of regulatory processes in Laos. As the online system is now the exclusive platform for registration, renewal, and amendments, companies that have not yet aligned their processes to the new system should act promptly to ensure a smooth transition. To assist with this, the FDD will conduct periodic training sessions on the use of the online registration system, which will be delivered either in person or remotely, depending on operator demand. To start using the system, drug and medical device manufacturers, as well as import-export companies, that have not yet registered must submit a formal request identifying the authorized personnel who will access the platform, after which they will be issued user accounts and access codes. Each request must be accompanied by the company’s enterprise registration certificate (incorporation certificate), a copy of the identity card or passport of each designated user, and a scanned copy of their signature. There is no restriction on the number of users per company, allowing flexibility to meet operational needs. Companies that already hold accounts and access codes from the trial phase may continue using them and may apply for additional accounts if needed. Additional Requirements The new system also introduces a standardized format for drug registration numbers. For example, an import drug registration number such as 06 I 4040/15 will be changed to 06-IM-04040-15, and a domestic drug registration number such as 06 L 4040/15 will be changed to
January 21, 2026
Spurred by global geopolitics and Canada’s Indo-Pacific Strategy, which aims to forge deeper ties with ASEAN, Canadian companies have been showing growing interest in Thailand and Southeast Asia in recent years. To understand the opportunities offered by the region, we sat down with Andrew Stoutley, a Toronto native and the chief operating officer of Tilleke & Gibbins, a leading Southeast Asian regional law firm with over 130 years of history in Thailand. Q: Why are Canadian companies looking at Thailand and Southeast Asia right now? A: Two reasons stand out. First, diversification has moved up the agenda. Many Canadian companies want options outside North America due to tariff volatility and policy uncertainty in the United States, as well as questions around the next Canada–United States–Mexico Agreement mandatory joint review. At the same time, the shift of global production from China to Southeast Asia is accelerating, driven by rising costs, geopolitics, and the need to avoid overreliance on a single market. As a result, Canadian companies are looking for a second production base or a regional hub, and Thailand and its neighbors are natural choices given their manufacturing depth, location, and established supply chains. Second, Canada’s own efforts in the region are gaining traction. The Indo-Pacific Strategy has led to more on-the-ground support, including larger trade missions, upgraded diplomatic posts, and new financing options. Export Development Canada (EDC) now has a presence in Bangkok, giving Canadian companies a direct line to financing and insurance in Thailand. There’s also steady progress on trade frameworks like the recently signed Canada–Indonesia Comprehensive Economic Partnership Agreement (which will come into effect pending domestic procedures), ongoing negotiations of a Canada–ASEAN FTA, and the exciting announcement about the launch of negotiations of a Canada–Thailand FTA. Together, these developments have the potential to make it much easier
January 8, 2026
Thailand’s approach to cannabis regulation has moved quickly from broad access to a medical, prescription‑only system. The latest government regulation classifies the cannabis flower as a controlled herb under the Thai Traditional Medicine Wisdom Act. The latest rules ban advertising and recreational sales, allow sales only to patients with prescriptions (up to 30 days), and require flowers to come from GACP‑certified (Good Agricultural and Collection Practices) farms. More importantly, cannabis dispensaries can only sell to patients presenting valid prescriptions issued by one of seven professions—medical doctors, Thai traditional practitioners, applied Thai traditional practitioners, traditional Chinese medicine practitioners, pharmacists, dentists, and folk healers—consistent with approved clinical indications. Noncompliance risks license suspension or revocation, and criminal penalties of up to one year’s imprisonment or a THB 20,000 fine. The dispensary‑only model that proliferated in Thailand in recent years is expected to end soon, as the rules will push all cannabis dispensaries into medical settings or retail pharmacies. Dispensaries must convert into medical establishments—clinics, pharmacies, or traditional pharmacies—complete with on‑site licensed practitioners as well as budtenders; strong controls for storage, hygiene, odor, and smoke; and facilities for record-keeping. All flowers dispensed or exported must come from GACP‑certified farms. If the government ends dispensaries outright and forces a conversion to clinics or pharmacies, compensation will not be automatic at the outset. As a result, business operators should plan for compliance and repurposing under the Medical Facilities Act, Modern Drug Act, and Herbal Product Act, which regulate medical clinics, modern pharmacies, and traditional medicine pharmacies, respectively. The table below summarizes the required licenses for clinics, pharmacies, and traditional medicine pharmacies selling cannabis flowers in Thailand. Aside from the specific listed licenses, all three types of establishments must also obtain a license to sell a controlled herb (cannabis flowers) from the Department of Thai Traditional
January 6, 2026
On December 30, 2025, Thailand’s Electronic Transactions Development Agency (ETDA) notified digital marketplace operators of a consolidated list of “high‑risk products” that are subject to strict monitoring on digital platforms. The list was jointly prepared by the Thai Industrial Standards Institute (TISI) and the Food and Drug Administration (FDA) to guide platform compliance in the initial phase of implementation of the Electronic Transaction Committee’s Notification on Other Measures for Marketplace for Goods with Specific Characteristics under Section 18(2) of the 2022 Royal Decree on Digital Platform Businesses Requiring Notification B.E.2568 (2025). The notice is addressed to operators of digital platform services that function as product marketplaces with specific characteristics laid out in the notification. The ETDA states that the TISI and the FDA are closely monitoring the high‑risk product categories on digital platforms, and the published list serves as the baseline reference for platform screening during the initial phase of the notification’s implementation. High‑Risk Product List The list aggregates categories of products that are illegal to sell online or are otherwise tightly regulated under Thai law, with an emphasis on health-related products, controlled substances, medical devices, and a wide range of industrial products that require certification or compliance with specified Thai Industrial Standards, as detailed below. Prohibited and tightly controlled health products. This includes all categories of modern medicines subject to control other than general household remedies; all categories of controlled herbal products except for over-the-counter herbal products; narcotics; psychotropic substances; and medical devices requiring use in medical facilities or a physician’s prescription. Selected industrial products requiring heightened controls. The list highlights dozens of TISI-regulated items commonly sold online. Examples include pacifiers, rice cookers, electrical wire, food wrap film, crayons, washing machines and dryers, air conditioners, electric cookers and air fryers, water heaters, microwave ovens, LED luminaires, hair dryers